Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63
Abstract Currently, infections with SARS-Coronavirus-2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic, are responsible for substantial morbidity and mortality worldwide. Older adults subjects > 60 years of age account for > 95% of the over one million fatal cases reported to date....
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/14096393e0f547299e16956eec9932db |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:14096393e0f547299e16956eec9932db |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:14096393e0f547299e16956eec9932db2021-12-02T16:18:06ZOlder adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL6310.1038/s41598-020-78506-92045-2322https://doaj.org/article/14096393e0f547299e16956eec9932db2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-78506-9https://doaj.org/toc/2045-2322Abstract Currently, infections with SARS-Coronavirus-2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic, are responsible for substantial morbidity and mortality worldwide. Older adults subjects > 60 years of age account for > 95% of the over one million fatal cases reported to date. It is unclear why in this age group SARS-CoV-2 infection causes more severe disease than in young adults. We hypothesized that differences in SARS-CoV-2 cross-reactive cellular immunity induced after infection with human coronaviruses (HCoVs), like OC43 and NL63, were at the basis of the differential mortality (and morbidity) observed after SARS-CoV-2 infection, because a small proportion of HCoV-specific T cells cross-react with SARS-CoV-2. Our data demonstrate that pre-existing T cell immunity induced by circulating human alpha- and beta-HCoVs is present in young adult individuals, but virtually absent in older adult subjects. Consequently, the frequency of cross-reactive T cells directed to the novel pandemic SARS-CoV-2 was minimal in most older adults. To the best of our knowledge, this is the first time that the presence of cross-reactive T cells to SARS-CoV-2 is compared in young and older adults. Our findings provide at least a partial explanation for the more severe clinical outcome of SARS-CoV-2 infection observed in the elderly. Moreover, this information could help to design efficacious vaccines for this age group, aiming at the induction of cell-mediated immunity.Giulietta SalettiThomas GerlachJanina M. JansenAntonia MolleHusni ElbaheshMartin LudlowWentao LiBerend-Jan BoschAlbert D. M. E. OsterhausGuus F. RimmelzwaanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-10 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Giulietta Saletti Thomas Gerlach Janina M. Jansen Antonia Molle Husni Elbahesh Martin Ludlow Wentao Li Berend-Jan Bosch Albert D. M. E. Osterhaus Guus F. Rimmelzwaan Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63 |
description |
Abstract Currently, infections with SARS-Coronavirus-2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic, are responsible for substantial morbidity and mortality worldwide. Older adults subjects > 60 years of age account for > 95% of the over one million fatal cases reported to date. It is unclear why in this age group SARS-CoV-2 infection causes more severe disease than in young adults. We hypothesized that differences in SARS-CoV-2 cross-reactive cellular immunity induced after infection with human coronaviruses (HCoVs), like OC43 and NL63, were at the basis of the differential mortality (and morbidity) observed after SARS-CoV-2 infection, because a small proportion of HCoV-specific T cells cross-react with SARS-CoV-2. Our data demonstrate that pre-existing T cell immunity induced by circulating human alpha- and beta-HCoVs is present in young adult individuals, but virtually absent in older adult subjects. Consequently, the frequency of cross-reactive T cells directed to the novel pandemic SARS-CoV-2 was minimal in most older adults. To the best of our knowledge, this is the first time that the presence of cross-reactive T cells to SARS-CoV-2 is compared in young and older adults. Our findings provide at least a partial explanation for the more severe clinical outcome of SARS-CoV-2 infection observed in the elderly. Moreover, this information could help to design efficacious vaccines for this age group, aiming at the induction of cell-mediated immunity. |
format |
article |
author |
Giulietta Saletti Thomas Gerlach Janina M. Jansen Antonia Molle Husni Elbahesh Martin Ludlow Wentao Li Berend-Jan Bosch Albert D. M. E. Osterhaus Guus F. Rimmelzwaan |
author_facet |
Giulietta Saletti Thomas Gerlach Janina M. Jansen Antonia Molle Husni Elbahesh Martin Ludlow Wentao Li Berend-Jan Bosch Albert D. M. E. Osterhaus Guus F. Rimmelzwaan |
author_sort |
Giulietta Saletti |
title |
Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63 |
title_short |
Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63 |
title_full |
Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63 |
title_fullStr |
Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63 |
title_full_unstemmed |
Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63 |
title_sort |
older adults lack sars cov-2 cross-reactive t lymphocytes directed to human coronaviruses oc43 and nl63 |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/14096393e0f547299e16956eec9932db |
work_keys_str_mv |
AT giuliettasaletti olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63 AT thomasgerlach olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63 AT janinamjansen olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63 AT antoniamolle olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63 AT husnielbahesh olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63 AT martinludlow olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63 AT wentaoli olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63 AT berendjanbosch olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63 AT albertdmeosterhaus olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63 AT guusfrimmelzwaan olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63 |
_version_ |
1718384155349221376 |